Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
J. Teng
Observed name:
J Teng
Institutions:
King's College London,
King's College Hospital NHS Foundation Trust
Observed institutions:
King's College London,
Bristol-Myers Squibb (United States),
King's College Hospital NHS Foundation Trust
OpenAlex ID:
A5113668077
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate
2008
·
G Wells
, J-C Becker
, et al.
·
Annals of the Rheumatic Diseases
·
988
PDF
Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy
2007
·
M C Genovese
, M Schiff
, et al.
·
Annals of the Rheumatic Diseases
·
293
Subcutaneous abatacept versus intravenous abatacept: A phase IIIb noninferiority study in patients with an inadequate response to methotrexate
2011
·
M. C. Genovese
, A. Covarrubias
, et al.
·
Arthritis & Rheumatism
·
205
PDF
Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial
2007
·
H K Genant
, C G Peterfy
, et al.
·
Annals of the Rheumatic Diseases
·
170
PDF
Muscle disorders * 111. The impact of fatigue in patients with idiopathic inflammatory myopathy: a mixed method study
2012
·
R. Campbell
, D. Hofmann
, et al.
·
Rheumatology
·
2
PDF
Absence de progression radiographique à 2 ans dans l'étude AIM (Abatacept in Rheumatoid arthritis patients with Inadequate response to MTX)
2006
·
B. Combe
, M. Dougados
, et al.
·
Revue du Rhumatisme
L'abatacept maintient sur deux ans l'inhibition de la progression radiographique chez des patients insuffisamment répondeurs au méthotrexate (MTX). Résultats à deux ans de l'étude AIM
2006
·
J. Sibilia
, B. Combe
, et al.
·
Revue du Rhumatisme
Abatacept Inhibits Radiographic Progression at 2 Yrs in Rheumatoid Arthritis (ra) Patients: the Long-term Extension of the Aim Trial
2006
·
Carlos Abud-Mendoza
, H K Genant
, et al.
·
JCR Journal of Clinical Rheumatology
Show more works
View as search
Works count:
9
Citation count:
1,658
H-index:
4
I10-index:
4
Year
Topic
Type